Department of Radiation Oncology, Henry Ford Health System, Detroit, Michigan.
Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan.
Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):236-245. doi: 10.1016/j.ijrobp.2016.09.007.
To determine our institutional vertebral compression fracture (VCF) rate after spine stereotactic radiosurgery (SRS) and determine contributory factors.
Retrospective analysis from 2001 to 2013 at a single institution was performed. With institutional review board approval, electronic medical records of 1905 vertebral bodies from 791 patients who were treated with SRS for the management of primary or metastatic spinal lesions were reviewed. A total of 448 patients (1070 vertebral bodies) with adequate follow-up imaging studies available were analyzed. Doses ranging from 10 Gy in 1 fraction to 60 Gy in 5 fractions were delivered. Computed tomography and magnetic resonance imaging were used to evaluate the primary endpoints of this study: development of a new VCF, progression of an existing VCF, and requirement of stabilization surgery after SRS.
A total of 127 VCFs (11.9%; 95% confidence interval [CI] 9.5%-14.2%) in 97 patients were potentially SRS induced: 46 (36%) were de novo, 44 (35%) VCFs progressed, and 37 (29%) required stabilization surgery after SRS. Our rate for radiologic VCF development/progression (excluding patients who underwent surgery) was 8.4%. Upon further exclusion of patients with hematologic malignancies the VCF rate was 7.6%. In the univariate analyses, females (hazard ratio [HR] 1.54, 95% CI 1.01-2.33, P=.04), prior VCF (HR 1.99, 95% CI 1.30-3.06, P=.001), primary hematologic malignancies (HR 2.68, 95% CI 1.68-4.28, P<.001), thoracic spine lesions (HR 1.46, 95% CI 1.02-2.10, P=.02), and lytic lesions had a significantly increased risk for VCF after SRS. On multivariate analyses, prior VCF and lesion type remained contributory.
Single-fraction SRS doses of 16 to 18 Gy to the spine seem to be associated with a low rate of VCFs. To the best of our knowledge, this is the largest reported experience analyzing SRS-induced VCFs, with one of the lowest event rates reported.
确定我们机构脊柱立体定向放射外科(SRS)后椎体压缩性骨折(VCF)的发生率,并确定相关因素。
对单一机构 2001 年至 2013 年的回顾性分析。经机构审查委员会批准,对 791 例接受 SRS 治疗原发性或转移性脊柱病变的患者的 1905 个椎体的电子病历进行了回顾性分析。对 448 例(1070 个椎体)有足够随访影像学研究的患者进行了分析。剂量范围从单次 10Gy 至 5 次 60Gy。使用计算机断层扫描和磁共振成像来评估本研究的主要终点:新发 VCF、现有 VCF 进展以及 SRS 后需要稳定手术。
97 例患者中共有 127 例(11.9%;95%置信区间 [CI] 9.5%-14.2%)可能为 SRS 引起的 VCF:46 例(36%)为新发,44 例(35%)VCF 进展,37 例(29%)SRS 后需要稳定手术。我们的影像学 VCF 发展/进展发生率(不包括接受手术的患者)为 8.4%。进一步排除血液恶性肿瘤患者后,VCF 发生率为 7.6%。在单变量分析中,女性(风险比 [HR] 1.54,95%CI 1.01-2.33,P=.04)、既往 VCF(HR 1.99,95%CI 1.30-3.06,P=.001)、原发性血液恶性肿瘤(HR 2.68,95%CI 1.68-4.28,P<.001)、胸段脊柱病变(HR 1.46,95%CI 1.02-2.10,P=.02)和溶骨性病变的患者 SRS 后 VCF 的风险显著增加。多变量分析中,既往 VCF 和病变类型仍然是相关因素。
单次 16 至 18Gy 脊柱 SRS 剂量似乎与 VCF 发生率低有关。据我们所知,这是分析 SRS 引起的 VCF 中报告经验最大的一次,也是报告的发生率最低的一次。